Liminal BioSciences Inc. carries a market capitalization of 27.62M, placing it among publicly traded companies globally.
| Market Cap | 27.62M |
| Enterprise Value | N/A |
Liminal BioSciences Inc.'s stock has gained approximately 67.32283% over the past 52 weeks. The 50-day moving average sits at 8.40, while the 200-day moving average is 6.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | 67.32283% |
| 50-Day Moving Average | 8.40 |
| 200-Day Moving Average | 6.20 |
| Average Volume (20 Days) | N/A |
Liminal BioSciences Inc.'s most recent stock split took place on February 1, 2023 with a 10:1 split ratio.
| Last Split Date | 2/1/2023 |
| Split Ratio | 10:1 |